IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study
Leng, Xi-sheng1; Zhao, Yong-jie2; Qiu, Hui-zhong3; Cao, Yong-kuan4; Zhu, Wei-hua1; Shen, Ju-fang5; Paschke, Amanda6; Dai, Wei-min7; Caldwell, Nicole6; Wang, Jue5
关键词Beta-lactams Ceftriaxone Metronidazole
刊名JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2014-12-01
DOI10.1093/jac/dku302
69期:12页:3379-3386
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Infectious Diseases ; Microbiology ; Pharmacology & Pharmacy
研究领域[WOS]Infectious Diseases ; Microbiology ; Pharmacology & Pharmacy
关键词[WOS]ANTIBIOTIC-PROPHYLAXIS ; CEFOTETAN PROPHYLAXIS ; METRONIDAZOLE ; CEFTRIAXONE ; TRIALS ; RATES
英文摘要

Our purpose was to evaluate ertapenem versus ceftriaxone/metronidazole for prophylaxis of surgical site infections (SSIs) following elective colorectal surgery in Chinese adult patients.

Eligible Chinese adults aged 18-80 years scheduled to undergo elective colorectal surgery by laparotomy were randomized to receive a 30 min infusion of 1 g of ertapenem/metronidazole placebo or 2 g of ceftriaxone/500 mg of metronidazole within 2 h before initial incision. The study endpoint was the proportion of patients with successful prophylaxis at 4 weeks after treatment. The primary analysis was based on the evaluable population (PP population) and the pre-specified non-inferiority margin was set at -15%. ClinicalTrials.gov: NCT01254344.

Of 599 patients randomized, 499 (251 ertapenem and 248 ceftriaxone) were eligible for inclusion in the PP population. The proportions of patients with successful prophylaxis in the ertapenem and ceftriaxone groups were 90.4% (227/251) and 90.3% (224/248), respectively. The difference in the proportion of successful outcomes was 0.1% (95% CI -5.2%, 5.5%). Unexplained antibiotic use was the most frequent reason for prophylaxis failure in both groups [ertapenem 4.8% (12/251), ceftriaxone 4.4% (11/248); difference 0.3%; 95% CI -3.6, 4.3]. Pathogen species isolated from SSI sources were consistent with previously conducted studies and the product package insert. The incidence of adverse events (AEs) was similar between the groups, with the most common AE being pyrexia [ertapenem 7.6% (22/290), ceftriaxone 5.7% (17/297)].

Ertapenem is as effective as ceftriaxone/metronidazole for SSI prophylaxis in patients undergoing elective colorectal surgery, and is well tolerated.

语种英语
WOS记录号WOS:000345767300029
资助机构Merck Co., Inc. ; Merck Sharp &amp ; Dohme Corp., China
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54758
专题北京大学第二临床医学院
作者单位1.Peking Univ, Peoples Hosp, Dept Surg, Beijing 100871, Peoples R China
2.Tianjin Peoples Hosp, Dept Surg, Tianjin, Peoples R China
3.Beijing Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China
4.Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China
5.MSD China, Shanghai, Peoples R China
6.Merck & Co Inc, Whitehouse Stn, NJ USA
7.PAREXEL Int, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Leng, Xi-sheng,Zhao, Yong-jie,Qiu, Hui-zhong,et al. Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,2014,69(12):3379-3386.
APA Leng, Xi-sheng.,Zhao, Yong-jie.,Qiu, Hui-zhong.,Cao, Yong-kuan.,Zhu, Wei-hua.,...&Wang, Jue.(2014).Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,69(12),3379-3386.
MLA Leng, Xi-sheng,et al."Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study".JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 69.12(2014):3379-3386.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Leng, Xi-sheng]的文章
[Zhao, Yong-jie]的文章
[Qiu, Hui-zhong]的文章
百度学术
百度学术中相似的文章
[Leng, Xi-sheng]的文章
[Zhao, Yong-jie]的文章
[Qiu, Hui-zhong]的文章
必应学术
必应学术中相似的文章
[Leng, Xi-sheng]的文章
[Zhao, Yong-jie]的文章
[Qiu, Hui-zhong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。